Scholar Rock Holding (SRRK) Current Assets (2017 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Current Assets of $515.3 million in Q1 2026, up 33.79% quarter-over-quarter from $385.1 million in Q4 2025, and up 33.75% on a YoY basis from $385.2 million in Q1 2025.
Scholar Rock Holding (SRRK) Current Assets (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Current Assets history runs 10 years deep, the most recent figure standing at $515.3 million for Q1 2026.
- In Q1 2026, Current Assets rose 33.75% year-over-year to $515.3 million; the TTM figure through Mar 2026 stood at $515.3 million (up 33.75% YoY), while the FY2025 annual figure was $385.1 million, down 14.63% from the prior year.
- Current Assets was $515.3 million for Q1 2026 at Scholar Rock Holding, up from $385.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $515.3 million in Q1 2026 to a low of $152.9 million in Q3 2024.
- Historically, Current Assets has averaged $318.4 million across 5 years, with a median of $319.1 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Current Assets sank 36.11% in 2023, then surged 155.49% in 2025.
- A 5-year view of Current Assets shows it stood at $328.0 million in 2022, then dropped by 12.14% to $288.2 million in 2023, then jumped by 56.55% to $451.2 million in 2024, then dropped by 14.63% to $385.1 million in 2025, then jumped by 33.79% to $515.3 million in 2026.
- The last three Current Assets figures came in at $515.3 million (Q1 2026), $385.1 million (Q4 2025), and $390.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | 515.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 515.28 Mn |
| Dec 31, 2025 | 385.15 Mn |
| Sep 30, 2025 | 390.71 Mn |
| Jun 30, 2025 | 319.13 Mn |
| Mar 31, 2025 | 385.25 Mn |
| Dec 31, 2024 | 451.17 Mn |
| Sep 30, 2024 | 152.93 Mn |
| Jun 30, 2024 | 199.14 Mn |
| Mar 31, 2024 | 246.93 Mn |
| Dec 31, 2023 | 288.19 Mn |
| Sep 30, 2023 | 228.47 Mn |
| Jun 30, 2023 | 259.81 Mn |
| Mar 31, 2023 | 287.16 Mn |
| Dec 31, 2022 | 328.02 Mn |
| Sep 30, 2022 | 357.61 Mn |
| Jun 30, 2022 | 389.14 Mn |
| Mar 31, 2022 | 228.59 Mn |
| Dec 31, 2021 | 265.32 Mn |
| Sep 30, 2021 | 258.16 Mn |
| Jun 30, 2021 | 290.37 Mn |